News

Important Update for United Parcel Service, Inc. Shareholders

Important Update for United Parcel Service, Inc. Shareholders

Critical Update for United Parcel Service, Inc. Investors

In light of recent events affecting United Parcel Service, Inc. (NYSE: UPS), investors are urged to pay close attention to a significant deadline concerning a securities fraud class action lawsuit. This important communication aims to guide shareholders about their rights and the necessary steps to take regarding their investments.

Understanding the Class Action Lawsuit

Bernstein Liebhard LLP, a leading investor rights law firm, has initiated this lawsuit on behalf of investors who purchased UPS securities during the specified Class Period. This typically includes shareholders who owned stocks between specific dates. For those who may have lost money due to these investments, understanding your rights is paramount.

Are You Affected?

If you have invested in United Parcel Service, it’s essential to reflect on the following questions:

  • Did you acquire shares of UPS?
  • Was your investment made between the specified dates?
  • Have you experienced financial losses with your investment?
  • Are you interested in discussing your rights as a shareholder?

Important Steps to Consider

The class action alleges that UPS and certain senior officers made misleading statements regarding the company's performance and ability to manage its operational demands. This case presents an opportunity for concerned investors to seek justice and potentially recover losses.

Filing as a Lead Plaintiff

Investors wishing to take a more active role may consider filing to serve as a lead plaintiff. Typically, this involves submitting the necessary documentation within a specified timeframe. Don't worry, even if you decide not to file, you can still remain a part of the class without additional obligations.

No Upfront Costs for Participants

Shareholders affected by the lawsuit can feel reassured knowing that all legal representation will be conducted on a contingency fee basis. This means there are no upfront costs, and investors will not be responsible for any legal fees unless the case reaches a favorable resolution.

Bernstein Liebhard LLP’s Record of Success

This firm has a notable history, having recovered over $3.5 billion for clients since its inception in 1993. It has successfully represented both individual investors and significant public and private pension funds, helping ensure their assets' safety through vigilant monitoring and active litigation.

Contact Information for Further Assistance

For any United Parcel Service investors seeking guidance or wishing to participate in the lawsuit, please reach out to:

Peter Allocco
Investor Relations Manager
Bernstein Liebhard LLP
(212) 951-2030
https://www.bernlieb.com
pallocco@bernlieb.com

Frequently Asked Questions

What is the deadline for filing as a lead plaintiff?

The deadline to file as a lead plaintiff is December 9, 2024.

Who can participate in the lawsuit?

Any investor who purchased UPS securities during the specified Class Period may contact the law firm for participation.

What does it mean to be a lead plaintiff?

A lead plaintiff represents the interests of the entire class in litigation and plays an active role in directing the lawsuit.

Are there any costs involved?

There are no costs for shareholders; representation by the firm operates on a contingency fee basis.

How can I get further information on the lawsuit?

Interested investors should contact the Investor Relations Manager or visit the firm's website for detailed guidance.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Liberty Hill: 50 Years of Grassroots Revolution

Updated Category News Views 4

Half a Century of Community Empowerment You don't see organizations sticking to their guns for fifty years without having something real to offer. Liberty Hill Foundation is celebrating this colossal milestone in style by throwing their weight behind 17 grassroots groups under the 2026 Fund for Change. They're not just tossing money around but are genuinely becoming the...

Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Updated Category News Views 6

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Continue Reading
Red-Eye Flights Surge, Driven By Western U.S. Routes

Updated Category News Views 5

You can always count on some things staying the same, right? Well, if you thought red-eye flights were going to fade away, think again. These late-night wonders are not just hanging around—they're booming in the west like there's no tomorrow. Literally. Champion Traveler has laid it all out for us: about 115,580 overnight flights in 2025, a record high since this mad...

Continue Reading
Rare Collectibles Highlight Morphy's Auction on Oct 4

Updated Category News Views 2

Anticipation Builds for Morphy's Auction Event Morphy's upcoming event on October 4th is all about tapping into the era of revved engines, gleaming gasoline signs, and some history that could put Hollywood tales to shame. The auction isn't just a stroll down memory lane; it features over 650 lots, each a time capsule of America's automotive past. From Al Capone's ritzy...

Continue Reading
AbbVie's Bold Leap in Menstrual Migraine Treatment

Updated Category News Views 10

AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...

Continue Reading
Veteran Marketer Joins The Wisory's Advisory Board

Updated Category News Views 3

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 3

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading
XKL Delivers MediaLight for High-Speed Optical Transport

Updated Category News Views 2

Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...

Continue Reading
CrossCountry Mortgage Boosts Loan Limits, Flexibility for 2027

Updated Category News Views 13

Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...

Continue Reading
Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Updated Category News Views 5

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

Continue Reading

Top 5 Most Recently Viewed Articles

UK's Public Sector Deficit Grows Amid Rising Debt Concerns

Updated Category News Views 258

Understanding the Growing UK Budget Deficit The recent data revealed a significant increase in the UK’s budget deficit, raising concerns regarding the country's fiscal management. With borrowing hitting 17.8 billion pounds, which is approximately $21.93 billion in December, this figure surpassed previous expectations and highlighted the growing financial strain on the...

Continue Reading
Masimo Achieves New Stock Milestone with Exciting Growth

Updated Category News Views 151

Masimo Corporation Reaches New Heights in Stock Performance Masimo Corporation (NASDAQ: MASI), a leading global medical technology company, has made headlines by reaching a remarkable 52-week high, with its stock valued at an impressive $173.91. This notable achievement signifies a robust upward trend within the market, showcasing an extraordinary 1-year growth change of...

Continue Reading
Discover Cutting-Edge Coding Solutions at Pack Expo 2024

Updated Category News Views 77

Videojet Showcases Solutions at Pack Expo 2024 At Pack Expo 2024, Videojet Technologies, a leader in coding, marking, and printing solutions, will present an array of innovative products tailored to enhance the efficiency of packaging operations. This year's event will take place at McCormick Place, booth S-2030, from November 3 to 6. The company is eager to connect with...

Continue Reading
BioNTech Reaches $1.25 Billion Settlement Over Vaccine Royalties

Updated Category News Views 190

BioNTech's Settlements: A Closer Look BioNTech, the renowned German biotechnology firm known for its role in developing the COVID-19 vaccine alongside Pfizer, has recently made headlines with two significant settlement agreements. The company announced that it has entered into these agreements with the U.S. National Institutes of Health and the University of Pennsylvania...

Continue Reading
Rado's Anatom Collection: A Seasonal Revamp for Everyone

Updated Category News Views 138

A Fresh Evolution of Rado's Design Icon As the summer season approaches, Rado is thrilled to introduce three captivating new versions of its iconic Anatom timepiece. These refreshed models, available globally, embody a perfect blend of modern design and enduring craftsmanship. Originally launched in the early 80s, the Anatom timepiece was revolutionary, introducing...

Continue Reading